002900 Stock Overview
Engages in the research, development, production, and sale of pharmaceutical product and medical devices in China.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 1/6 |
Harbin Medisan Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥8.03 |
| 52 Week High | CN¥15.49 |
| 52 Week Low | CN¥6.74 |
| Beta | 0.41 |
| 11 Month Change | -5.42% |
| 3 Month Change | -16.35% |
| 1 Year Change | -39.03% |
| 33 Year Change | -63.91% |
| 5 Year Change | -31.78% |
| Change since IPO | -53.71% |
Recent News & Updates
Harbin Medisan Pharmaceutical (SZSE:002900) Posted Weak Earnings But There Is More To Worry About
Sep 05
Harbin Medisan Pharmaceutical (SZSE:002900) Will Pay A Larger Dividend Than Last Year At CN¥0.20
Jun 01Recent updates
Harbin Medisan Pharmaceutical (SZSE:002900) Posted Weak Earnings But There Is More To Worry About
Sep 05Harbin Medisan Pharmaceutical (SZSE:002900) Will Pay A Larger Dividend Than Last Year At CN¥0.20
Jun 01Is Harbin Medisan Pharmaceutical (SZSE:002900) A Risky Investment?
May 23Harbin Medisan Pharmaceutical Co., Ltd.'s (SZSE:002900) Price Is Right But Growth Is Lacking After Shares Rocket 27%
Mar 08Shareholder Returns
| 002900 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | 0.1% | -0.7% | 0.4% |
| 1Y | -39.0% | -16.8% | -18.8% |
Return vs Industry: 002900 underperformed the CN Pharmaceuticals industry which returned -16.8% over the past year.
Return vs Market: 002900 underperformed the CN Market which returned -18.8% over the past year.
Price Volatility
| 002900 volatility | |
|---|---|
| 002900 Average Weekly Movement | 4.5% |
| Pharmaceuticals Industry Average Movement | 5.2% |
| Market Average Movement | 5.4% |
| 10% most volatile stocks in CN Market | 8.6% |
| 10% least volatile stocks in CN Market | 3.6% |
Stable Share Price: 002900 has not had significant price volatility in the past 3 months.
Volatility Over Time: 002900's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1996 | 2,115 | Jian Fei Qin | www.medisan.com.cn |
Harbin Medisan Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of pharmaceutical product and medical devices in China. The company offers various drugs for nervous system, cardiovascular system, musculoskeletal system, systemic anti-infective, basic infusions, nutritional infusion, anti-tumor and immunomodulators, digestive tract, metabolism, etc. It also produces and sells cosmetics. Harbin Medisan Pharmaceutical Co., Ltd.
Harbin Medisan Pharmaceutical Co., Ltd. Fundamentals Summary
| 002900 fundamental statistics | |
|---|---|
| Market cap | CN¥2.49b |
| Earnings (TTM) | CN¥47.75m |
| Revenue (TTM) | CN¥1.07b |
52.1x
P/E Ratio2.3x
P/S RatioIs 002900 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 002900 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.07b |
| Cost of Revenue | CN¥493.38m |
| Gross Profit | CN¥579.63m |
| Other Expenses | CN¥531.88m |
| Earnings | CN¥47.75m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.15 |
| Gross Margin | 54.02% |
| Net Profit Margin | 4.45% |
| Debt/Equity Ratio | 42.0% |
How did 002900 perform over the long term?
See historical performance and comparison